Cardiovascular Revascularization Medicine Cardiovascular Revascularization Medicine RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

STEMI with fluctuating closing of LAD and Cx
Case report of the male with an anterior STEMI to whom a primary PCI is performed. The angiogram shows a fluctuating close of the LAD and Cx than when an OCT is performed is not clearly seem any pathological findings but when the IVUS is performed, it is clearly seem a coronary haematoma at the LM, LAD and Cx. Stent at the LM-LAD and proximal Cx are implanted with final good result. After exchange the guiding catheter for a diagnostic catheter to visualize the RCA, there is an aortic flap, the coronary haematoma was coming from an ascending aortic dissection. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - March 27, 2017 Category: Cardiology Authors: Mario Sadaba, Asier Subinas, Jose Ram ón Rumoroso Source Type: research

Immediate and short-term performance of a novel sirolimus-coated balloon during complex percutaneous coronary interventions. The FAtebenefratelli SIrolimus COated-balloon (FASICO) registry
Drug-coated balloons (DCB) currently represent an alternative to drug-eluting stents (DES) for the treatment of in-stent restenosis and they are also variably used for small coronary vessel and bifurcation lesion management. All DCB variably elute paclitaxel as an anti-proliferative drug. The first sirolimus coated balloon (SCB) received the CE mark in 2016, but its clinical performance has not been shown yet. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - March 24, 2017 Category: Cardiology Authors: Bernardo Cortese, Gaetano di Palma, Roberto A. Latini, Mostafa Elwany, Pedro Silva Orrego, Romano G. Seregni Source Type: research

First experience of drug-coated balloons for treatment of bioresorbable vascular scaffold restenosis
The aim of this study is to evaluate the role of drug-coated balloons (DCB) for the management of bioresorbable vascular scaffold (BVS) restenosis. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - March 24, 2017 Category: Cardiology Authors: Mostafa Elwany, Roberto Adriano Latini, Gaetano Di Palma, Pedro Silva Orrego, Bernardo Cortese Source Type: research

How Good is EPS at Predicting the Future After TAVR?
Permanent pacemaker (PPM) implantation continues to be a significant complication of transcatheter aortic valve replacement (TAVR), occurring in approximately 12% of patients [1]. While device enhancements of new TAVR valves, better patient selection and operator experience have led to a decrease in paravalvular regurgitation, vascular injury, stroke, and new dialysis requirement, pacemaker implantation appears to be the only complication that is increasing in frequency [1]. As TAVR expands to patients with lower risk, the long-term consequences of pacemaker implantation will likely be amplified. (Source: Cardiovascular Re...
Source: Cardiovascular Revascularization Medicine - March 24, 2017 Category: Cardiology Authors: Brett A. Oestreich, Santiago Garcia Source Type: research

Use of multi-lumen catheters to preserve injected stem cell viability and injectant dispersion
This study investigates the effect of a new injection catheter design which is intended to resist the deleterious effect of balloon compression on cell viability for various flowrates, balloon pressures, and fluid viscosity values. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - March 24, 2017 Category: Cardiology Authors: E.M. Sparrow, B.B. Nelson-Cheeseman, W.J. Minkowycz, J.M. Gorman, J.P. Abraham Source Type: research

Factors Affecting Cardiovascular and Cerebrovascular Complications of Carotid Artery Stenting in Northern Michigan, A Retrospective Study
This study seeks to identify factors associated with periprocedural complications of carotid artery stenting (CAS) to best understand CAS complication rates and optimize patient outcomes. Periprocedural complications include major adverse cardiovascular and cerebrovascular events (MACCE) that include myocardial infarction (MI), stroke, or death. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - March 24, 2017 Category: Cardiology Authors: Dalia F. Mammo, Chin-I Cheng, Neli P. Ragina, Firas Alani Source Type: research

Immediate and short term performance of a novel sirolimus-coated balloon during complex percutaneous coronary interventions. The FAtebenefratelli SIrolimus COated-balloon (FASICO) registry
drug-coated balloons (DCB) currently represent an alternative to drug-eluting stents (DES) for the treatment of in-stent restenosis and they are also variably used for small coronary vessel and bifurcation lesion management. All DCB variably elute paclitaxel as an anti-proliferative drug. The first Sirolimus coated balloon (SCB) received the CE mark in 2016, but its clinical performance has not been shown yet. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - March 24, 2017 Category: Cardiology Authors: Bernardo Cortese, Gaetano di Palma, Roberto A. Latini, Mostafa Elwany, Pedro Silva Orrego, Romano G. Seregni Source Type: research

Descending septal branch of right coronary artery: Rare, but important in hypertrophic cardiomyopathy
We describe our case and the relevant literature available for use of this anatomical variant in alcohol septal ablation. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - March 24, 2017 Category: Cardiology Authors: Arka Chatterjee, Ethan T. Oates, Massoud A. Leesar, Oluseun O. Alli Source Type: research

Giant coronary aneurysm management with Viabahn covered stent
A 68year old female patient underwent coronary artery bypass surgery (CABG) 1year previously. At that time she had a giant coronary artery aneurysm (CAA) of the proximal right coronary artery and severe 3 vessel disease including a severe ostial right coronary artery stenosis, severe stenosis of the proximal and mid left anterior descending artery (LAD) and a totally occluded left circumflex artery. She underwent CABG including left internal mammary artery to LAD, aorto-saphenous venous graft (ASVG) to posterior descending artery and ASVG sequential to the first diagonal and obtuse marginal branch. (Source: Cardiovascular ...
Source: Cardiovascular Revascularization Medicine - March 23, 2017 Category: Cardiology Authors: Tae-Hoon Kim, Ravi Marfatia, Juyong Lee, Michael Azrin Source Type: research

Influence about the Flow of Distal Branch after Intervention of the Right Coronary Artery Chronic Total Occlusion
Limited data are available for the clinical outcomes after the recanalization of right coronary artery (RCA) chronic total occlusion (CTO). The study aims to assess the clinical outcomes in the antegrade flow of the distal branch after successful RCA CTO percutaneous coronary intervention (PCI). (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - March 21, 2017 Category: Cardiology Authors: Hsiu-Yu Fang, Chiung-Jen Wu, Chih-Yuan Fang, Wei-Chieh Lee Source Type: research

A Single Center Retrospective Analysis of Patency Rates of Intraluminal versus Subintimal Endovascular Revascularization of Long Femoropopliteal Occlusions
The evaluation of patency rates of intraluminal versus subintimal endovascular revascularization of long femoro-popliteal (FP) lesions. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - March 20, 2017 Category: Cardiology Authors: Anvar Babaev, Pawan Hari, Rohit Gokhale, Susanna Zavlunova Source Type: research

Stent loss during chronic total occlusion percutaneous coronary intervention: optical coherence tomography-guided stent ‘crushing and trapping
Stent loss is currently an infrequent complication during percutaneous coronary intervention (PCI) [1]. However, it can have devastating consequences, including stent thrombosis, myocardial infarction and death [2]. Here we describe a case of stent loss during chronic total occlusion (CTO) PCI that was successfully managed by meticulous optical coherence tomography (OCT)-guided stent crushing and trapping. We additionally review the incidence and possible mechanisms of stent loss during PCI, and provide a set of recommendations to manage such complication. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - March 20, 2017 Category: Cardiology Authors: Luciano Candilio, Satoru Mitomo, Mauro Carlino, Antonio Colombo, Lorenzo Azzalini Source Type: research

Conduction Disturbances After TAVR: Electrophysiological Studies and Pacemaker Dependency
Permanent pacemaker (PPM) placement occurs in 5 –20% of patients after transcatheter aortic valve replacement (TAVR). Although predictors of pacemaker implantation have been established, features that predispose patients to pacemaker utilization on follow up have not been widely reported. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - March 15, 2017 Category: Cardiology Authors: Nader Makki, Jenn Dollery, Danielle Jones, Juan Crestanello, Scott Lilly Source Type: research

A Case of Severely Calcified Neoatherosclerosis after Paclitaxel Eluting Stent Implantation
A 79-year-old male who had a history of coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) received coronary angiography (CAG), because of angina pectoris. CAG showed in-stent restenosis of the paclitaxel-eluting stent (PES). Since the devices could not pass the lesion, we performed rotational atherectomy. Although we could not identify the calcified lesion by the optical frequency domain imaging (OFDI) findings because of strong attenuation, the intravascular ultrasound (IVUS) image showed the superficial calcification. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - March 15, 2017 Category: Cardiology Authors: Kei Yamamoto, Kenichi Sakakura, Yousuke Taniguchi, Hiroshi Wada, Shin-ichi Momomura, Hideo Fujita Source Type: research

Out of hospital cardiac arrest: concise review of strategies to improve outcome
Despite decades of research, cardiac arrest remains a major cause of morbidity and mortality, with frustratingly poor survival rates of approximately 10% to hospital discharge. Various strategies have been shown to improve survival, but differing degrees of implementation have led to a disparity in survival rates. These improvements, however, are balanced against the increasing age of patients presenting with out of hospital cardiac arrest and decreasing incidence of ventricular fibrillation, the rhythm with the best outcome. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - March 15, 2017 Category: Cardiology Authors: Richard J. Jabbour, Sayan Sen, Ghada W. Mikhail, Iqbal S Malik Source Type: research